PAVmed Corporate Presentation
2020 Annual Meeting of Stockholders
For Fiscal Year Ending Dec 31, 2019
Receive updates straight into your inbox
PAVmed Inc. is a highly differentiated, multiproduct medical device company employing a unique business model designed to advance innovative products to commercialization much more rapidly and with significantly less capital than the typical medical device company. This proprietary model enables PAVmed to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation. PAVmed’s diversified pipeline of products address unmet clinical needs encompassing a broad spectrum of clinical areas with attractive regulatory pathways and market opportunities. Its five lead technologies provide groundbreaking approaches to carpal tunnel syndrome (CarpX™), precancerous conditions of the esophagus (EsoGuard™/EsoCheck™), vascular access (PortIO™), pediatric ear infections (DisappEAR™) and medical infusions (NextFlo™). The company is also developing innovative products in other areas, such as catheters and tissue ablation, while seeking to further expand its pipeline through engagements with clinician innovators and leading academic medical centers.
One Grand Central Place Suite 4600 New York, NY 10165
Mike Havrilla Director of Investor Relations T: 814-241-4138 JMH@PAVmed.com
Continental Stock Transfer & Trust Company 17 Battery Place New York, NY 10004